Overview

U.S. Biliary Stents Market is poised to value over USD 513.5 million by 2027 end at a CAGR of over 5.2% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of U.S. Biliary Stents Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the U.S. Biliary Stents Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the U.S. Biliary Stents Market:
• Abbott Laboratories
• Boston Scientific Corporation
• Conmed Corporation
• Cook Medical
• B. Braun Melsungen AG
• Medtronic plc
• Terumo Corporation
• Merit Medical
• Olympus Corporation
• Becton Dickinson and Company
(Note: The list of the major players will be updated with the latest market scenario and trends)

U.S. Biliary Stents Market Segmentation:

By Type
• Metal biliary stents
• Plastic biliary stents

By Application
• Malignant obstruction
• Benign biliary strictures
• Biliary leaks
• Others
 
By End-User
• Hospitals
• Ambulatory Surgical Centers

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the U.S. Biliary Stents Market By Type, By Application and By End-User.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— U.S.
• To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global U.S. Biliary Stents Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of U.S. Biliary Stents Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global U.S. Biliary Stents Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. U.S. Biliary Stents Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Metal biliary stents
  7.2. Plastic biliary stents
 
8. U.S. Biliary Stents Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)  
  8.1. Malignant obstruction
  8.2. Benign biliary strictures
  8.3. Biliary leaks
  8.4. Others
     
9. U.S. Biliary Stents Market, By End-User Historical Analysis and Forecast 2020-2027 (USD Million)  
  9.1. Hospitals
  9.2. Ambulatory Surgical Centers
 
10. Market Share Analysis and Competitive Landscape  
   10.1. U.S. Landscape - Key Players, Revenue and Presence
   10.2. U.S. Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   10.3. U.S. Emerging Companies
   10.4. U.S. Key Player - Growth Matrix

11. Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts)
   11.1. Abbott Laboratories
         11.1.1. Company Overview
         11.1.2. Product Portfolio
         11.1.3. SWOT Analysis
         11.1.4. Financial Overview
         11.1.5. Strategic Overview
   11.2. Boston Scientific Corporation
         11.2.1. Company Overview
         11.2.2. Product Portfolio
         11.2.3. SWOT Analysis
         11.2.4. Financial Overview
         11.2.5. Strategic Overview
   11.3. Conmed Corporation
         11.3.1. Company Overview
         11.3.2. Product Portfolio
         11.3.3. SWOT Analysis
         11.3.4. Financial Overview
         11.3.5. Strategic Overview
   11.4. Cook Medical
         11.4.1. Company Overview
         11.4.2. Product Portfolio
         11.4.3. SWOT Analysis
         11.4.4. Financial Overview
         11.4.5. Strategic Overview
   11.5. B. Braun Melsungen AG
         11.5.1. Company Overview
         11.5.2. Product Portfolio
         11.5.3. SWOT Analysis
         11.5.4. Financial Overview
         11.5.5. Strategic Overview          
   11.6. Medtronic plc
         11.6.1. Company Overview
         11.6.2. Product Portfolio
         11.6.3. SWOT Analysis
         11.6.4. Financial Overview
         11.6.5. Strategic Overview      
   11.7. Terumo Corporation
         11.7.1. Company Overview
         11.7.2. Product Portfolio
         11.7.3. SWOT Analysis
         11.7.4. Financial Overview
         11.7.5. Strategic Overview
   11.8. Merit Medical
         11.8.1. Company Overview
         11.8.2. Product Portfolio
         11.8.3. SWOT Analysis
         11.8.4. Financial Overview
         11.8.5. Strategic Overview
   11.9. Olympus Corporation
         11.9.1. Company Overview
         11.9.2. Product Portfolio
         11.9.3. SWOT Analysis
         11.9.4. Financial Overview
         11.9.5. Strategic Overview
   11.10.Becton, Dickinson and Company
         11.10.1. Company Overview
         11.10.2. Product Portfolio
         11.10.3. SWOT Analysis
         11.10.4. Financial Overview
         11.10.5. Strategic Overview
   
12. Pre and Post COVID-19 Impact
   12.1. Positive influence on the healthcare industry
   12.2. The financial disruption of the manufacturing sector
   12.3. Impact of COVID-19 on emerging companies
   12.4. Significant mandates in the healthcare regulations initiated by administrations
   12.5. The overall economic slowdown of the developing and developed nations

13. FutureWise SME Key Takeaway Points for Client

Tables

Figures